by Mayo Clinic News Network, Mayo Clinic News Network Credit: CC0 Public DomainHepatitis is inflammation in the liver caused by specific viruses. The hepatitis viruses are referred to as types A, B, C, D and E. All types affect the liver, but they differ in illness severity and prevention options. In the U.S., the most...
by Rockefeller University The RNA launch system. Credit: Science Advances (2023). DOI: 10.1126/sciadv.adg6265 Hepatitis C and hepatitis B viruses both attack the liver, eventually causing deadly cirrhosis or cancer. But while antivirals can cure 95% of HCV infections, its cousin HBV has long eluded effective therapeutics. As a result, nearly 1 million people die from HBV every year....
by University of California, Los Angeles The study included a complementary translational approach with both preclinical in vitro studies and clinical studies using accessible PBMCs from HIV-1(−) participants (men and women) and people with HIV (PWH) with suppressed plasma viremia on TAF-based versus TDF-based ART. Credit: Theodoros Kelesidis New UCLA-led research suggests that antiretroviral drugs called TAF...
by George Mason University Credit: Unsplash/CC0 Public Domain Hepatitis B virus (HBV) infection is the leading cause of cirrhosis and primary liver cancer, globally affecting nearly 300 million people. In the United States, Asian Americans account for 7% of the total population, but more than 50% of all HBV infections. Foreign-born Asian Americans face tremendous...
by University College London Credit: CC0 Public Domain Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world. Each year, globally, chronic HBV causes an estimated 880,000 deaths from liver cirrhosis and hepatocellular carcinoma/liver cancer (HCC). The pioneering study used immune cells isolated...
Lauren Chase Lauren Chase is on the Research Team at GoodRx. Posted on August 11, 2020 In an effort to continue to shed light on drug prices and increase transparency, the GoodRx Research Team regularly tracks the most expensive drugs in the U.S. Since 2018, we have tracked the list price and dosing requirements to...
by Elsevier A report in the Journal of Molecular Diagnostics describes a new and powerful laboratory tool that may improve the diagnosis and treatment of hepatitis B virus (HBV) infection. The technique can simultaneously assess several indicators important for optimal patient management. A team of scientists has developed a highly sensitive coamplification at lower denaturation temperature...
July 27, 2018, Westmead Institute for Medical Research A new study has shown that genetic variation may increase the risk of severe liver damage in Caucasians with chronic hepatitis B infection. First author Dr. Rasha El Sharkawy. Credit: The Westmead Institute for Medical Research Researchers from the Westmead Institute for Medical Research found that Caucasian...
Dr. Robert Lanford works in his lab at Texas Biomed. Research at the Southwest National Primate Research Center (SNPRC) on the campus of Texas Biomedical Research Institute helped advance a new treatment now in human trials for chronic hepatitis B virus (HBV) infection. Testing at SNPRC provided proof this novel therapeutic approach and drug...
(HealthDay)—Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily low-dose aspirin therapy may prevent cancer, but there is little clinical evidence on whether regular aspirin use can prevent liver cancer...
